Other Briefings
Where to Invest in China’s Biopharma Boom: Mapping the Big Three Clusters in 2026
China now generates close to a third of the world’s innovative-drug pipeline, and foreign multinationals are committing billions to specific addresses. We map where the capital is going, and why each of China’s three anchor life sciences clusters suits a different kind of investor.
Non-Compete Agreements in China: A Guide for Foreign Employers
Non-compete agreements in China only bind certain employees and must meet strict tests on eligibility, compensation, and proportionality. This guide explains what foreign employers must do to keep their clauses enforceable, and what to check in their contracts.
Hong Kong Refines Fund and Family Office Tax Regime: Key Changes and Implications
Hong Kong’s 2026 tax bill expands incentives for funds, asset managers, and family offices under the Unified Fund Exemption. Explore key changes and implications.
China Monthly Tax Brief: June 2026
Our June 2026 tax brief covers a new VAT filing pilot, real-time petrol invoicing rules, OECD remote-work PE guidance, and new foreign investment incentives, among other important updates foreign businesses should know.
China Tightens Contract Food Manufacturing Rules: What Foreign Companies Need to Know
New rules taking effect on December 1, 2026 make brand owners jointly responsible for the safety of food produced under contract in China. We outline what existing companies and new market entrants need to do to comply.
Setting Up a Business in Hong Kong: What is the Full Cost?
Setting up a business in Hong Kong involves a range of costs that go well beyond the initial registration fees. This guide breaks down every major expense, from incorporation and visas to office rents and payroll obligations.
China’s New Foreign Investment Action Plan: The Measures That Matter Most for FIEs
China’s 2026 action plan for foreign investment opens financial services, revises M&A rules, and eases data export controls. We outline the most important measures for FIEs and discuss how to act on them.
AI-Powered HR in China: Who’s Liable When Algorithms Decide?
AI is changing how HR functions operate in China, but it does not change who is accountable. Technology may automate processes, but legal responsibility remains firmly with the employer.
